Vimarsana
Biggest News Aggregation in the World

Page 19 - Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sclerosis Today - Breaking & Trending Today

£1.6 million grant awarded to advance development of MND drug candidate - Vimarsana News

£1.6 million grant awarded to advance development of MND drug candidate

£1.6 million grant awarded to advance development of MND drug candidate Researchers from the University of Sheffield's Institute for Translational Neuroscience (SITraN) have been awarded a £1.6 million grant from the Medical Research Council (MRC). The grant will support their partnership with Aclipse Therapeutics to advance the translational development of M102 - a drug candidate for the treatment of motor neuron disease (MND). Neuroprotective properties of M102 were discovered by SITraN researchers in 2013. Preclinical models evidenced the potential for M102 to slow down MND progression, ...

Inflammation of the brain gray matter decreases nerve-cell activity in mouse model - Vimarsana News

Inflammation of the brain gray matter decreases nerve-cell activity in mouse model

Inflammation of the brain gray matter decreases nerve-cell activity in mouse model Damage to the brain gray matter plays an important role in the progression of multiple sclerosis. This study now shows that such damage can be caused by inflammatory reactions that lead to loss of synapses, which impairs neural activity. Multiple sclerosis (MS) is a chronic inflammatory disease that affects the central nervous system, in which nerve cells are attacked by the patient's own immune system. In many cases, the disease develops into a progressive form, which is characterized by a shift of pathology f...

Hematopoietic stem cell transplants may prevent worsening of MS disability - Vimarsana News

Hematopoietic stem cell transplants may prevent worsening of MS disability

Hematopoietic stem cell transplants may prevent worsening of MS disability A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. The research is published in the January 20, 2021, online issue of Neurology ®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after treatment. Additionally, more th...

ALS study underscores the unique genetics of Maltese population - Vimarsana News

ALS study underscores the unique genetics of Maltese population

ALS study underscores the unique genetics of Maltese population Malta, a sovereign microstate in the middle of the Mediterranean Sea, has no shortage of sunny beaches, honey-bricked villages and rugged countryside. Beyond its Mediterranean charm, Malta is home to a geographically and culturally isolated population whose unique genetic makeup, makes this island nation a goldmine for genetics research. Four years ago, the University of Malta set up a national ALS Registry and Biobank to identify patients with amyotrophic lateral sclerosis (ALS) and collect data on their residence, occupation, l...

Global Multiple Sclerosis Market 2021 Trends, Research, Analysis & Review Forecast 2027 - Vimarsana News

Global Multiple Sclerosis Market 2021 Trends, Research, Analysis & Review Forecast 2027

Global Multiple Sclerosis Market 2021 Trends, Research, Analysis & Review Forecast 2027